Kai-Uwe Schöning

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Light Stabilizers. Top assignees: Basf Se Corporation, Ciba Specialty Chemicals Corporation, Teva Pharmaceutical Industries Limited. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai-Uwe Schöning. Retrieved from https://idiyas.com/inventor/kai-uwe-schoning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 58.8

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 15 (Patent Applications = 20)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

Windisch, CH (2006 - 2009)
Oberwil, CH (2006 - 2018)

Company Filing History:

Ciba Specialty Chemicals Corporation

patents

1 out of 505

Teva Pharmaceutical Industries Limited

patents

Years Active: 2006-2018

Loading Chart...

Areas of Expertise:

Sterically Hindered Amines

Light Stabilizers

Oligomeric Stabilizers

Anti-Microbial Compositions

Atorvastatin Crystalline Forms

Enzymatic Catalysis

Phenolic Carboxylic Acids

Organosilicon Photoinitiators

Tricyclic Alkoxyamines

3-Aminocarboxylic Acids

Metal Complexes

Nitroxyl Ethers

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10040762 - Sterically hindered amines (2018-08-07),

2. 9969864 - Light stabilizers (2018-05-15),

3. 9963575 - Sterically hindered amine light stabilizers with a mixed functionalization (2018-05-08),

4. 9556326 - Oligomeric light stabilizers with a specific functionalization (2017-01-31),

5. 9550941 - Sterically hindered amine light stabilizers with a mixed functionalization (2017-01-24),

6. 9458380 - 5H-furan-2-one derivatives for stabilization of organic material (2016-10-04),

7. 9045480 - Sterically hindered amine light stabilizers (2015-06-02),

8. 8598369 - Bi—or tricyclic sterically hindered alkoxyamines and process for their preparation (2013-12-03),

9. 8524812 - Stabilizers (2013-09-03),

10. 8481726 - Process for the preparation of sterically hindered nitroxyl ethers (2013-07-09),

11. 8471031 - Process for the preparation of sterically hindered nitroxyl ethers (2013-06-25),

12. 8232305 - Anti-microbial compositions (2012-07-31),

13. 7682404 - Coloring keratin fibers with metal complexes (2010-03-23),

14. 7538136 - Crystalline forms of atorvastatin (2009-05-26),

15. 7507853 - Process for the preparation of phenolic carboxylic acid derivatives by enzymatic catalysis (2009-03-24),

Title: The Innovative Mind of Kai-Uwe Schöning

Introduction: Kai-Uwe Schöning, a talented inventor hailing from Oberwil, Switzerland, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kai-Uwe Schöning's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including advancements in robotics, artificial intelligence, and sustainable energy.

Career Highlights: With a career spanning over two decades, Kai-Uwe Schöning has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new possibilities in the ever-evolving tech landscape.

Collaborations: Throughout his career, Kai-Uwe Schöning has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Kai-Uwe Schöning's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazer in the world of technology. His contributions continue to inspire the next generation of inventors and shape the future of innovation.

Profile summary based on public USPTO records.